Page last updated: 2024-12-08

dimoxamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dimoxamine: butyl analog of DOM (2-amino-1-(2,5-dimethoxy-4-methylphenyl)propane) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3037161
CHEMBL ID433696
SCHEMBL ID894999
MeSH IDM0048413

Synonyms (21)

Synonym
dimoxamine
dimoxamine, (r)-
CHEMBL433696
(2r)-1-(2,5-dimethoxy-4-methylphenyl)butan-2-amine
benzeneethanamine, alpha-ethyl-2,5-dimethoxy-4-methyl-, (r)-
unii-09426zto78
dimoxamin
52842-59-8
(r)-1-(2,5-dimethoxy-4-methylphenyl)-2-butylamin
09426zto78 ,
mdpa-1
benzeneethanamine, .alpha.-ethyl-2,5-dimethoxy-4-methyl-, (r)-
(.alpha.r)-.alpha.-ethyl-2,5-dimethoxy-4-methylbenzeneethanamine
(r)-.alpha.-ethyl-2,5-dimethoxy-4-methylphenethylamine
benzeneethanamine, .alpha.-ethyl-2,5-dimethoxy-4-methyl-, (.alpha.r)-
SCHEMBL894999
r-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane
benzeneethanamine, a-ethyl-2,5-dimethoxy-4-methyl-, (ar)-
AMY19359
DTXSID30967314
benzeneethanamine,a-ethyl-2,5-dimethoxy-4-methyl-,(ar)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID123319Compound was evaluated for hallucinogenic activity in mice; Inactive1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (87.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]